Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
bioAffinity Technologies, Inc. is a biotechnology company focused on the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments. It develops noninvasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis developed by machine learning, a form of artificial intelligence (AI). The Company's product, CyPath Lung, is a noninvasive test that has shown high sensitivity, specificity and accuracy for the detection of early-stage lung cancer. CyPath is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Laboratory Services, a subsidiary of the Company. The Company is developing noninvasive tests using its flow cytometry platform to quantify lung inflammation and precision diagnostics to assist physicians in selecting drugs for patients with asthma and chronic obstructive pulmonary disease (COPD).
Find out what a historical investment in bioAffinity Technologies Inc would be worth today using our BIAF stock calculator.
Buying BIAF shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in bioAffinity Technologies Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in BIAF
What is the ticker symbol of bioAffinity Technologies Inc?
The ticker symbol for bioAffinity Technologies Inc is BIAF.
How much is one share of BIAF?
One share of BIAF is valued at $1.85 as of 20 November 2026.
What is the market capitalisation of bioAffinity Technologies Inc BIAF?
As of 20 November 2026 bioAffinity Technologies Inc has a market cap of $3.91M.
What is the 52-week high for bioAffinity Technologies Inc stock?
The bioAffinity Technologies Inc 52-week high stock price is $80.70.
What is the 52-week low for bioAffinity Technologies Inc stock?
The bioAffinity Technologies Inc 52-week low stock price is $1.84.
Can I buy BIAF shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BIAF shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BIAF on Stake
Buy BIAF from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of BIAF from only US$10 with fractional shares